HYBClass I
Eosin Y
21 CFR 864.1850 / Hematology
HYB is the FDA product code for Eosin Y, a class I device type, regulated under 21 CFR 864.1850. As of , FDA records hold 10 510(k) clearances under this code, the most recent dated , and 3 recalls.
Classification record
- Product code
- HYB
- Device name
- Eosin Y
- Regulation
- 21 CFR 864.1850
- Device class
- Class I
- Review panel
- Hematology
- Submission type
- 510(k) exempt
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- Yes
- Third party review eligible
- No
- Ingested clearances
- 10
- Ingested recalls
- 3
Clearances, product code HYB
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1980 | 1 |
| 1981 | 2 |
| 1982 | 3 |
| 1984 | 1 |
| 1988 | 2 |
| 1989 | 1 |
Applicants with the most clearances
Product code HYB| Applicant | Clearances |
|---|---|
| Sigma Chemical Co. | 3 |
| Shandon, Inc. | 2 |
| Accra Laboratories, Inc. | 1 |
| EMD Millipore Corporation | 1 |
| Richard-Allan Medical Ind., Inc. | 1 |
| Surgipath | 1 |
| Volu Sol Medical Industries | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this code- AD Supply Group Limited
- Agilent Technologies Denmark ApS
- Agilent Technologies, Inc.
- ANATECH division of Cancer Diagnostics, Inc.
- ATSI Logistics Center ApS
- Avantor Performance Materials, LLC
- Azer Scientific, Inc.
- Biocare Medical LLC
- Cancer Diagnostics, Inc.
- Chaptec America
- CITOTEST Labware Manufacturing CO., Ltd.
- Citotest Scientific Co.,Ltd.
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
